Laboratory Corporation of America Holdings Stock
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
199.4 USD | -0.26% | -3.41% | -12.25% |
Financials (USD)
Sales 2024 * | 12.76B | Sales 2025 * | 13.31B | Capitalization | 16.82B |
---|---|---|---|---|---|
Net income 2024 * | 995M | Net income 2025 * | 1.11B | EV / Sales 2024 * | 1.66 x |
Net Debt 2024 * | 4.35B | Net Debt 2025 * | 3.85B | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
16.9
x | P/E ratio 2025 * |
15.1
x | Employees | 61,975 |
Yield 2024 * |
1.48% | Yield 2025 * |
1.53% | Free-Float | 99.66% |
Latest transcript on Laboratory Corporation of America Holdings
1 day | -0.26% | ||
1 week | -3.41% | ||
Current month | -8.70% | ||
1 month | -4.82% | ||
3 months | -12.26% | ||
6 months | -1.14% | ||
Current year | -12.25% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 14-06-15 |
Compliance Officer | 65 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 07-05-15 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Director/Board Member | 74 | 95-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 2 M€ | +6.54% | ||
1.95% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 199.4 | -0.26% | 768,682 |
24-04-17 | 200 | -0.97% | 683,299 |
24-04-16 | 201.9 | -0.68% | 691,528 |
24-04-15 | 203.3 | -1.17% | 669,066 |
24-04-12 | 205.7 | -0.37% | 717,036 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.25% | 16.82B | |
-12.12% | 86.47B | |
+9.72% | 82.27B | |
+10.85% | 29.43B | |
-5.06% | 15.89B | |
-8.68% | 14.1B | |
+1.87% | 12.05B | |
-30.00% | 12.01B | |
+20.38% | 11.19B | |
-4.03% | 11.09B |
- Stock Market
- Equities
- LH Stock